Changes in metabolic-related variables during chronic morphine treatment

Neurochemistry International

Volumn 57, Issue 3, 2010, Pages 323-330

  Ferenczi, Szilamér ^a   Núñez, Cristina ^b   Pintér Kübler, Bernadett ^a   Földes, Anna ^a   Martín, Fátima ^b   Ladnyánszky Márkus, Vera ^a   Milanés, M Victoria ^b   Kovács, Krisztina J ^a  

^a INSTITUTE OF EXPERIMENTAL MEDICINE   (Hungary)

^b UNIVERSITY OF MURCIA   (Spain)

Author keywords

CART; Feeding behavior; FosB; Insulin; Leptin; NPY

Indexed keywords

ADIPONECTIN; CORTICOTROPIN; GLUCOSE; INSULIN; LEPTIN; MORPHINE; NEUROPEPTIDE Y; OREXIN; PLACEBO; PROOPIOMELANOCORTIN; TRANSCRIPTION FACTOR DELTA FOSB; TRANSCRIPTION FACTOR FOSB; GLUCOSE BLOOD LEVEL; HORMONE; NARCOTIC ANALGESIC AGENT; NEUROPEPTIDE; PRIMER DNA; PROTEIN C FOS;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTERIOR HYPOTHALAMUS; APPETITE DISORDER; ARCUATE NUCLEUS; ARTICLE; BEHAVIOR CHANGE; CALORIC INTAKE; CIRCADIAN RHYTHM; CONTROLLED STUDY; CORTICOTROPIN BLOOD LEVEL; ENERGY BALANCE; ENERGY EXPENDITURE; FEEDING BEHAVIOR; FOOD INTAKE; GENE EXPRESSION; GLUCOSE BLOOD LEVEL; HORMONE RELEASE; HYPOTHALAMUS VENTROMEDIAL NUCLEUS; IMMUNOREACTIVITY; IMPLANT; INSULIN BLOOD LEVEL; LATERAL HYPOTHALAMUS; MALE; METABOLIC INHIBITION; NONHUMAN; PRIORITY JOURNAL; RAT; WEIGHT REDUCTION; WHITE ADIPOSE TISSUE; ANIMAL; ANIMAL BEHAVIOR; BIOSYNTHESIS; BRAIN STEM; DRUG EFFECTS; ENERGY METABOLISM; GENETICS; HYPOTHALAMUS; IMMUNOHISTOCHEMISTRY; METABOLISM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WEIGHT GAIN; WISTAR RAT;

ADIPOSE TISSUE, WHITE; ANALGESICS, OPIOID; ANIMALS; BEHAVIOR, ANIMAL; BLOOD GLUCOSE; BRAIN STEM; DNA PRIMERS; ENERGY METABOLISM; FEEDING BEHAVIOR; HORMONES; HYPOTHALAMUS; IMMUNOHISTOCHEMISTRY; MALE; METABOLISM; MORPHINE; NEUROPEPTIDES; PROTO-ONCOGENE PROTEINS C-FOS; RATS; RATS, WISTAR; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; WEIGHT GAIN;

ANIMALIA; RATTUS; RATTUS NORVEGICUS;

EID: 77955095816     PISSN: 01970186     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuint.2010.06.011     Document Type: Article

References (51)

1. Abizaid A., Liu Z.W., Andrews Z.B., Shanabrough M., Borok E., Elsworth J.D., Roth R.H., Sleeman M.W., Picciotto M.R., Tschop M.H., Gao X.B., Horvath T.L. Ghrelin modulates the activity and synaptic input organization of midbrain dopamine neurons while promoting appetite. J. Clin. Invest. 2006, 116:3229-3239.
2. Abs R., Verhelst J., Maeyaert J., Van Buyten J.P., Opsomer F., Adriaensen H., Verlooy J., Van Havenbergh T., Smet M., Van Acker K. Endocrine consequences of long-term intrathecal administration of opioids. J. Clin. Endocrinol. Metab. 2000, 85:2215-2222.
3. Atkinson R.L. Opioid regulation of food intake and body weight in humans. Fed. Proc. 1987, 46:178-182.
4. Bhakthan N.M., Chiu S. Deranged diurnal feeding pattern and altered brain serotonin turnover in heroin-dependent rats. Arch. Int. Pharmacodyn. Ther. 1978, 235:289-298.
5. Bodnar R.J. Endogenous opioids and feeding behavior: a 30-year historical perspective. Peptides 2004, 25:697-725.
6. Bronstein D.M., Przewlocki R., Akil H. Effects of morphine treatment on pro-opiomelanocortin systems in rat brain. Brain Res. 1990, 519:102-111.
7. Chen H., Vlahos R., Bozinovski S., Jones J., Anderson G.P., Morris M.J. Effect of short-term cigarette smoke exposure on body weight, appetite and brain neuropeptide Y in mice. Neuropsychopharmacology 2005, 30:713-719.
8. Chen S.A., O'Dell L.E., Hoefer M.E., Greenwell T.N., Zorrilla E.P., Koob G.F. Unlimited access to heroin self-administration: independent motivational markers of opiate dependence. Neuropsychopharmacology 2006, 31:2692-2707.
9. Cicero T.J., Meyer E.R. Morphine pellet implantation in rats: quantitative assessment of tolerance and dependence. J. Pharmacol. Exp. Ther. 1973, 184:404-408.
10. Cota D., Tschop M.H., Horvath T.L., Levine A.S. Cannabinoids, opioids and eating behavior: the molecular face of hedonism?. Brain Res. Rev. 2006, 51:85-107.
11. Cowley M.A., Smart J.L., Rubinstein M., Cerdan M.G., Diano S., Horvath T.L., Cone R.D., Low M.J. Leptin activates anorexigenic POMC neurons through a neural network in the arcuate nucleus. Nature 2001, 411:480-484.
12. Curran H.V., Robjant K. Eating attitudes, weight concerns and beliefs about drug effects in women who use ecstasy. J. Psychopharmacol. 2006, 20:425-431.
13. Dhatt R.K., Rattan A.K., Mangat H.K. Effect of chronic intracerebroventricular morphine to feeding responses in male rats. Physiol. Behav. 1988, 43:553-557.
14. Figlewicz D.P., Bennett J.L., Aliakbari S., Zavosh A., Sipols A.J. Insulin acts at different CNS sites to decrease acute sucrose intake and sucrose self-administration in rats. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2008, 295:R388-394.
15. Fuertes G., Laorden M.L., Milanes M.V. Noradrenergic and dopaminergic activity in the hypothalamic paraventricular nucleus after naloxone-induced morphine withdrawal. Neuroendocrinology 2000, 71:60-67.
16. Garcia de Yebenes E., Pelletier G. Opioid regulation of proopiomelanocortin (POMC) gene expression in the rat brain as studied by in situ hybridization. Neuropeptides 1993, 25:91-94.
17. He L., Kim J.A., Whistler J.L. Biomarkers of morphine tolerance and dependence are prevented by morphine-induced endocytosis of a mutant mu-opioid receptor. FASEB J. 2009, 23:4327-4334.
18. Hernandez L., Hoebel B.G. Food reward and cocaine increase extracellular dopamine in the nucleus accumbens as measured by microdialysis. Life Sci. 1988, 42:1705-1712.
19. Hommel J.D., Trinko R., Sears R.M., Georgescu D., Liu Z.W., Gao X.B., Thurmon J.J., Marinelli M., DiLeone R.J. Leptin receptor signaling in midbrain dopamine neurons regulates feeding. Neuron 2006, 51:801-810.
20. Houshyar H., Gomez F., Manalo S., Bhargava A., Dallman M.F. Intermittent morphine administration induces dependence and is a chronic stressor in rats. Neuropsychopharmacology 2003, 28:1960-1972.
21. Houshyar H., Manalo S., Dallman M.F. Time-dependent alterations in mRNA expression of brain neuropeptides regulating energy balance and hypothalamo-pituitary-adrenal activity after withdrawal from intermittent morphine treatment. J. Neurosci. 2004, 24:9414-9424.
22. Israel Y., Kandov Y., Khaimova E., Kest A., Lewis S.R., Pasternak G.W., Pan Y.X., Rossi G.C., Bodnar R.J. NPY-induced feeding: pharmacological characterization using selective opioid antagonists and antisense probes in rats. Peptides 2005, 26:1167-1175.
23. Kalivas P.W., Volkow N.D. The neural basis of addiction: a pathology of motivation and choice. Am. J. Psychiatry 2005, 162:1403-1413.
24. Kelley A.E., Baldo B.A., Pratt W.E., Will M.J. Corticostriatal-hypothalamic circuitry and food motivation: integration of energy, action and reward. Physiol. Behav. 2005, 86:773-795.
25. Khawaja X.Z., Bailey C.J., Green I.C. Central mu, delta, and kappa opioid binding sites, and brain and pituitary beta-endorphin and met-enkephalin in genetically obese (ob/ob) and lean mice. Life Sci. 1989, 44:1097-1105.
26. Kovacs K.J., Makara G.B. Corticosterone and dexamethasone act at different brain sites to inhibit adrenalectomy-induced adrenocorticotropin hypersecretion. Brain Res. 1988, 474:205-210.
27. Levine A.S., Grace M., Billington C.J., Gosnell B.A., Krahn D.D., Brown D.M., Morley J.E. Effect of morphine and nalmefene on energy balance in diabetic and non-diabetic rats. Pharmacol. Biochem. Behav. 1988, 29:495-500.
28. Levine A.S., Morley J.E., Gosnell B.A., Billington C.J., Bartness T.J. Opioids and consummatory behavior. Brain Res. Bull. 1985, 14:663-672.
29. Lucca G., Comim C.M., Valvassori S.S., Reus G.Z., Vuolo F., Petronilho F., Dal-Pizzol F., Gavioli E.C., Quevedo J. Effects of chronic mild stress on the oxidative parameters in the rat brain. Neurochem. Int. 2009, 54:358-362.
30. Mocchetti I., Ritter A., Costa E. Down-regulation of proopiomelanocortin synthesis and beta-endorphin utilization in hypothalamus of morphine-tolerant rats. J. Mol. Neurosci. 1989, 1:33-38.
31. Morley J.E., Flood J.F. An investigation of tolerance to the actions of leptogenic and anorexigenic drugs in mice. Life Sci. 1987, 41:2157-2165.
32. Nader K., Bechara A., van der Kooy D. Lesions of the lateral parabrachial nucleus block the aversive motivational effects of both morphine and morphine withdrawal but spare morphine's discriminative properties. Behav. Neurosci. 1996, 110:1496-1502.
33. Nunez C., Foldes A., Laorden M.L., Milanes M.V., Kovacs K.J. Activation of stress-related hypothalamic neuropeptide gene expression during morphine withdrawal. J. Neurochem. 2007, 101:1060-1071.
34. Nunez C., Martin F., Foldes A., Luisa Laorden M., Kovacs K.J., Victoria Milanes M. Induction of FosB/deltaFosB in the brain stress system-related structures during morphine dependence and withdrawal. J. Neurochem. 2010, 114:457-487.
35. Olausson P., Jentsch J.D., Tronson N., Neve R.L., Nestler E.J., Taylor J.R. DeltaFosB in the nucleus accumbens regulates food-reinforced instrumental behavior and motivation. J. Neurosci. 2006, 26:9196-9204.
36. Pages N., Orosco M., Fournier G., Rouch C., Hafi A., Gourch A., Comoy E., Bohuon C. The effects of chronic administration of morphine on the levels of brain and adrenal catecholamines and neuropeptide Y in rats. Gen. Pharmacol. 1991, 22:943-947.
37. Palmiter R.D. Is dopamine a physiologically relevant mediator of feeding behavior?. Trends Neurosci. 2007, 30:375-381.
38. Perrotti L.I., Hadeishi Y., Ulery P.G., Barrot M., Monteggia L., Duman R.S., Nestler E.J. Induction of deltaFosB in reward-related brain structures after chronic stress. J. Neurosci. 2004, 24:10594-10602.
39. Shimomura Y., Oku J., Glick Z., Bray G.A. Opiate receptors, food intake and obesity. Physiol. Behav. 1982, 28:441-445.
40. Shuey D.L., Woodland C., Tremblay C., Gregson R., Gerson R.J. Oxymorphone hydrochloride, a potent opioid analgesic, is not carcinogenic in rats or mice. Toxicol. Sci. 2007, 96:162-173.
41. Silva R.M., Grossman H.C., Rossi G.C., Pasternak G.W., Bodnar R.J. Pharmacological characterization of beta-endorphin- and dynorphin A(1-17)-induced feeding using G-protein alpha-subunit antisense probes in rats. Peptides 2002, 23:1101-1106.
42. Sood A., Thakur V.S., Karmarkar M.G., Ahuja M.M. Effect of chronic morphine administration on glucose tolerance and insulin binding to isolated rat adipocytes. Endocr. Res. 2001, 27:215-221.
43. Taheri S., Sunter D., Dakin C., Moyes S., Seal L., Gardiner J., Rossi M., Ghatei M., Bloom S. Diurnal variation in orexin A immunoreactivity and prepro-orexin mRNA in the rat central nervous system. Neurosci. Lett. 2000, 279:109-112.
44. Thornhill J.A., Hirst M., Gowdey C.W. Disruption of diurnal feeding patterns of rats by heroin. Pharmacol. Biochem. Behav. 1976, 4:129-135.
45. Tsujino N., Sakurai T. Orexin/hypocretin: a neuropeptide at the interface of sleep, energy homeostasis, and reward system. Pharmacol. Rev. 2009, 61:162-176.
46. Wardlaw S.L., Kim J., Sobieszczyk S. Effect of morphine on proopiomelanocortin gene expression and peptide levels in the hypothalamus. Brain Res. Mol. Brain Res. 1996, 41:140-147.
47. Watanabe M., Tamano H., Kikuchi T., Takeda A. Susceptibility to stress in young rats after 2-week zinc deprivation. Neurochem. Int. 2010, 56:410-416.
48. Yamanaka A., Beuckmann C.T., Willie J.T., Hara J., Tsujino N., Mieda M., Tominaga M., Yagami K., Sugiyama F., Goto K., Yanagisawa M., Sakurai T. Hypothalamic orexin neurons regulate arousal according to energy balance in mice. Neuron 2003, 38:701-713.
49. Yu Y., South T., Wang Q., Huang X.F. Differential expression of hypothalamic CART mRNA in response to body weight change following different dietary interventions. Neurochem. Int. 2008, 52:1422-1430.
50. Zheng H., Townsend R.L., Shin A., Patterson L.M., Phifer C.B., Berthoud H.R. High-fat intake induced by mu-opioid activation of the nucleus accumbens is inhibited by Y1R-blockade and MC3/4R-stimulation. Brain Res. 2010, 10.1016/j.brainres.2010.03.061.
51. Zheng S.X., Bosch M.A., Ronnekleiv O.K. mu-opioid receptor mRNA expression in identified hypothalamic neurons. J. Comp. Neurol. 2005, 487:332-344.